バイオシミラーのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Biosimilar Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16069 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

バイオシミラー市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のバイオシミラーの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のバイオシミラーの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 バイオシミラー市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・注射、錠剤、その他 用途別セグメントは次のように区分されます。 ・強直性脊椎炎、腫瘍、関節リウマチ、心臓血管、その他 世界のバイオシミラー市場の主要な市場プレーヤーは以下のとおりです。 ・CP Guojian Pharma、Biotech Pharma、Celgen Pharma、Henlius、Amgen、Eli Lilly、Sandoz、Changchun High Tech、Innovent 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、バイオシミラー製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なバイオシミラーメーカーの企業概要、2019年～2021年までのバイオシミラーの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なバイオシミラーメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別バイオシミラーの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのバイオシミラーの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのバイオシミラー市場予測を収録しています。 ・第12、13、14章では、バイオシミラーの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：CP Guojian Pharma、Biotech Pharma、Celgen Pharma、Henlius、Amgen、Eli Lilly、Sandoz、Changchun High Tech、Innovent ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：注射、錠剤、その他 ・用途別分析2016年-2026年：強直性脊椎炎、腫瘍、関節リウマチ、心臓血管、その他 ・バイオシミラーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・バイオシミラーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・バイオシミラーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・バイオシミラーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・バイオシミラーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Biosimilar Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Biosimilar Drug size is estimated to be XX million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Biosimilar Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Biosimilar Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Injection
Tablets
Other Types

Market segment by Application can be divided into
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application

The key market players for global Biosimilar Drug market are listed below:
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
Amgen
Eli Lilly
Sandoz
Changchun High Tech
Innovent

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Biosimilar Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosimilar Drug, with price, sales, revenue and global market share of Biosimilar Drug from 2019 to 2021.
Chapter 3, the Biosimilar Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilar Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Biosimilar Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Biosimilar Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Biosimilar Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biosimilar Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Injection
1.2.3 Tablets
1.2.4 Other Types
1.3 Market Analysis by Application
1.3.1 Overview: Global Biosimilar Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Ankylosing Spondylitis
1.3.3 Tumor
1.3.4 Rheumatoid Arthrtis
1.3.5 Cardiovascular
1.3.6 Other Application
1.4 Global Biosimilar Drug Market Size & Forecast
1.4.1 Global Biosimilar Drug Sales in Value (2016-2026))
1.4.2 Global Biosimilar Drug Sales in Volume (2016-2026)
1.4.3 Global Biosimilar Drug Price by Type (2016-2026) & (USD/Dose)
1.5 Global Biosimilar Drug Production Capacity Analysis
1.5.1 Global Biosimilar Drug Total Production Capacity (2016-2026)
1.5.2 Global Biosimilar Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Biosimilar Drug Market Drivers
1.6.2 Biosimilar Drug Market Restraints
1.6.3 Biosimilar Drug Trends Analysis
2 Manufacturers Profiles
2.1 CP Guojian Pharma
2.1.1 CP Guojian Pharma Details
2.1.2 CP Guojian Pharma Major Business
2.1.3 CP Guojian Pharma Biosimilar Drug Product and Services
2.1.4 CP Guojian Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Biotech Pharma
2.2.1 Biotech Pharma Details
2.2.2 Biotech Pharma Major Business
2.2.3 Biotech Pharma Biosimilar Drug Product and Services
2.2.4 Biotech Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Celgen Pharma
2.3.1 Celgen Pharma Details
2.3.2 Celgen Pharma Major Business
2.3.3 Celgen Pharma Biosimilar Drug Product and Services
2.3.4 Celgen Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Henlius
2.4.1 Henlius Details
2.4.2 Henlius Major Business
2.4.3 Henlius Biosimilar Drug Product and Services
2.4.4 Henlius Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Biosimilar Drug Product and Services
2.5.4 Amgen Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Biosimilar Drug Product and Services
2.6.4 Eli Lilly Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Sandoz
2.7.1 Sandoz Details
2.7.2 Sandoz Major Business
2.7.3 Sandoz Biosimilar Drug Product and Services
2.7.4 Sandoz Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Changchun High Tech
2.8.1 Changchun High Tech Details
2.8.2 Changchun High Tech Major Business
2.8.3 Changchun High Tech Biosimilar Drug Product and Services
2.8.4 Changchun High Tech Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Innovent
2.9.1 Innovent Details
2.9.2 Innovent Major Business
2.9.3 Innovent Biosimilar Drug Product and Services
2.9.4 Innovent Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Biosimilar Drug Sales by Manufacturer
3.1 Global Biosimilar Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Biosimilar Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Biosimilar Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Biosimilar Drug Manufacturer Market Share
3.4.2 Top 6 Biosimilar Drug Manufacturer Market Share
3.5 Global Biosimilar Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Biosimilar Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Biosimilar Drug Market Size by Region
4.1.1 Global Biosimilar Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Biosimilar Drug Revenue by Region (2016-2026)
4.2 North America Biosimilar Drug Revenue (2016-2026)
4.3 Europe Biosimilar Drug Revenue (2016-2026)
4.4 Asia-Pacific Biosimilar Drug Revenue (2016-2026)
4.5 South America Biosimilar Drug Revenue (2016-2026)
4.6 Middle East and Africa Biosimilar Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Biosimilar Drug Sales in Volume by Type (2016-2026)
5.2 Global Biosimilar Drug Revenue by Type (2016-2026)
5.3 Global Biosimilar Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Biosimilar Drug Sales in Volume by Application (2016-2026)
6.2 Global Biosimilar Drug Revenue by Application (2016-2026)
6.3 Global Biosimilar Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Biosimilar Drug Sales by Type (2016-2026)
7.2 North America Biosimilar Drug Sales by Application (2016-2026)
7.3 North America Biosimilar Drug Market Size by Country
7.3.1 North America Biosimilar Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Biosimilar Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Biosimilar Drug Sales by Type (2016-2026)
8.2 Europe Biosimilar Drug Sales by Application (2016-2026)
8.3 Europe Biosimilar Drug Market Size by Country
8.3.1 Europe Biosimilar Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Biosimilar Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Biosimilar Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Biosimilar Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Biosimilar Drug Market Size by Region
9.3.1 Asia-Pacific Biosimilar Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Biosimilar Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Biosimilar Drug Sales by Type (2016-2026)
10.2 South America Biosimilar Drug Sales by Application (2016-2026)
10.3 South America Biosimilar Drug Market Size by Country
10.3.1 South America Biosimilar Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Biosimilar Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Biosimilar Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Biosimilar Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Biosimilar Drug Market Size by Country
11.3.1 Middle East & Africa Biosimilar Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Biosimilar Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Biosimilar Drug Typical Distributors
12.3 Biosimilar Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Biosimilar Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Biosimilar Drug Revenue by Application, (USD Million), 2021-2026
Table 3. CP Guojian Pharma Basic Information, Manufacturing Base and Competitors
Table 4. CP Guojian Pharma Major Business
Table 5. CP Guojian Pharma Biosimilar Drug Product and Services
Table 6. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Biotech Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Biotech Pharma Major Business
Table 9. Biotech Pharma Biosimilar Drug Product and Services
Table 10. Biotech Pharma Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Celgen Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Celgen Pharma Major Business
Table 13. Celgen Pharma Biosimilar Drug Product and Services
Table 14. Celgen Pharma Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Henlius Basic Information, Manufacturing Base and Competitors
Table 16. Henlius Major Business
Table 17. Henlius Biosimilar Drug Product and Services
Table 18. Henlius Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Amgen Basic Information, Manufacturing Base and Competitors
Table 20. Amgen Major Business
Table 21. Amgen Biosimilar Drug Product and Services
Table 22. Amgen Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly Major Business
Table 25. Eli Lilly Biosimilar Drug Product and Services
Table 26. Eli Lilly Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sandoz Basic Information, Manufacturing Base and Competitors
Table 28. Sandoz Major Business
Table 29. Sandoz Biosimilar Drug Product and Services
Table 30. Sandoz Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Changchun High Tech Basic Information, Manufacturing Base and Competitors
Table 32. Changchun High Tech Major Business
Table 33. Changchun High Tech Biosimilar Drug Product and Services
Table 34. Changchun High Tech Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Innovent Basic Information, Manufacturing Base and Competitors
Table 36. Innovent Major Business
Table 37. Innovent Biosimilar Drug Product and Services
Table 38. Innovent Biosimilar Drug Sales (K Dose), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Biosimilar Drug Sales by Manufacturer (2019-2021e) & (K Dose)
Table 40. Global Biosimilar Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Biosimilar Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Biosimilar Drug Production Capacity by Company, (K Dose): 2020 VS 2021
Table 43. Head Office and Biosimilar Drug Production Site of Key Manufacturer
Table 44. Biosimilar Drug New Entrant and Capacity Expansion Plans
Table 45. Biosimilar Drug Mergers & Acquisitions in the Past Five Years
Table 46. Global Biosimilar Drug Sales by Region (2016-2021e) & (K Dose)
Table 47. Global Biosimilar Drug Sales by Region (2021-2026) & (K Dose)
Table 48. Global Biosimilar Drug Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global Biosimilar Drug Revenue by Region (2021-2026) & (USD Million)
Table 50. Global Biosimilar Drug Sales by Type (2016-2021e) & (K Dose)
Table 51. Global Biosimilar Drug Sales by Type (2021-2026) & (K Dose)
Table 52. Global Biosimilar Drug Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global Biosimilar Drug Revenue by Type (2021-2026) & (USD Million)
Table 54. Global Biosimilar Drug Price by Type (2016-2021e) & (USD/Dose)
Table 55. Global Biosimilar Drug Price by Type (2021-2026) & (USD/Dose)
Table 56. Global Biosimilar Drug Sales by Application (2016-2021e) & (K Dose)
Table 57. Global Biosimilar Drug Sales by Application (2021-2026) & (K Dose)
Table 58. Global Biosimilar Drug Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global Biosimilar Drug Revenue by Application (2021-2026) & (USD Million)
Table 60. Global Biosimilar Drug Price by Application (2016-2021e) & (USD/Dose)
Table 61. Global Biosimilar Drug Price by Application (2021-2026) & (USD/Dose)
Table 62. North America Biosimilar Drug Sales by Country (2016-2021e) & (K Dose)
Table 63. North America Biosimilar Drug Sales by Country (2021-2026) & (K Dose)
Table 64. North America Biosimilar Drug Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America Biosimilar Drug Revenue by Country (2021-2026) & (USD Million)
Table 66. North America Biosimilar Drug Sales by Type (2016-2021e) & (K Dose)
Table 67. North America Biosimilar Drug Sales by Type (2021-2026) & (K Dose)
Table 68. North America Biosimilar Drug Sales by Application (2016-2021e) & (K Dose)
Table 69. North America Biosimilar Drug Sales by Application (2021-2026) & (K Dose)
Table 70. Europe Biosimilar Drug Sales by Country (2016-2021e) & (K Dose)
Table 71. Europe Biosimilar Drug Sales by Country (2021-2026) & (K Dose)
Table 72. Europe Biosimilar Drug Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe Biosimilar Drug Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe Biosimilar Drug Sales by Type (2016-2021e) & (K Dose)
Table 75. Europe Biosimilar Drug Sales by Type (2021-2026) & (K Dose)
Table 76. Europe Biosimilar Drug Sales by Application (2016-2021e) & (K Dose)
Table 77. Europe Biosimilar Drug Sales by Application (2021-2026) & (K Dose)
Table 78. Asia-Pacific Biosimilar Drug Sales by Region (2016-2021e) & (K Dose)
Table 79. Asia-Pacific Biosimilar Drug Sales by Region (2021-2026) & (K Dose)
Table 80. Asia-Pacific Biosimilar Drug Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific Biosimilar Drug Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific Biosimilar Drug Sales by Type (2016-2021e) & (K Dose)
Table 83. Asia-Pacific Biosimilar Drug Sales by Type (2021-2026) & (K Dose)
Table 84. Asia-Pacific Biosimilar Drug Sales by Application (2016-2021e) & (K Dose)
Table 85. Asia-Pacific Biosimilar Drug Sales by Application (2021-2026) & (K Dose)
Table 86. South America Biosimilar Drug Sales by Country (2016-2021e) & (K Dose)
Table 87. South America Biosimilar Drug Sales by Country (2021-2026) & (K Dose)
Table 88. South America Biosimilar Drug Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America Biosimilar Drug Revenue by Country (2021-2026) & (USD Million)
Table 90. South America Biosimilar Drug Sales by Type (2016-2021e) & (K Dose)
Table 91. South America Biosimilar Drug Sales by Type (2021-2026) & (K Dose)
Table 92. South America Biosimilar Drug Sales by Application (2016-2021e) & (K Dose)
Table 93. South America Biosimilar Drug Sales by Application (2021-2026) & (K Dose)
Table 94. Middle East & Africa Biosimilar Drug Sales by Country (2016-2021e) & (K Dose)
Table 95. Middle East & Africa Biosimilar Drug Sales by Country (2021-2026) & (K Dose)
Table 96. Middle East & Africa Biosimilar Drug Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa Biosimilar Drug Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa Biosimilar Drug Sales by Type (2016-2021e) & (K Dose)
Table 99. Middle East & Africa Biosimilar Drug Sales by Type (2021-2026) & (K Dose)
Table 100. Middle East & Africa Biosimilar Drug Sales by Application (2016-2021e) & (K Dose)
Table 101. Middle East & Africa Biosimilar Drug Sales by Application (2021-2026) & (K Dose)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Biosimilar Drug Typical Distributors
Table 105. Biosimilar Drug Typical Customers
List of Figures
Figure 1. Biosimilar Drug Picture
Figure 2. Global Biosimilar Drug Sales Market Share by Type in 2020
Figure 3. Injection
Figure 4. Tablets
Figure 5. Other Types
Figure 6. Global Biosimilar Drug Sales Market Share by Application in 2020
Figure 7. Ankylosing Spondylitis
Figure 8. Tumor
Figure 9. Rheumatoid Arthrtis
Figure 10. Cardiovascular
Figure 11. Other Application
Figure 12. Global Biosimilar Drug Market Size, (USD Million) & (K Dose): 2020 VS 2021 VS 2026
Figure 13. Global Biosimilar Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Biosimilar Drug Sales (2016-2026) & (K Dose)
Figure 15. Global Biosimilar Drug Price by Type (2016-2026) & (USD/Dose)
Figure 16. Global Biosimilar Drug Production Capacity (2016-2026) & (K Dose)
Figure 17. Global Biosimilar Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Biosimilar Drug Market Drivers
Figure 19. Biosimilar Drug Market Restraints
Figure 20. Biosimilar Drug Market Trends
Figure 21. Global Biosimilar Drug Sales Market Share by Manufacturer in 2020
Figure 22. Global Biosimilar Drug Revenue Market Share by Manufacturer in 2020
Figure 23. Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Biosimilar Drug Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Biosimilar Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Biosimilar Drug Sales Market Share by Region (2016-2026)
Figure 27. Global Biosimilar Drug Revenue Market Share by Region (2016-2026)
Figure 28. North America Biosimilar Drug Revenue (2016-2026) & (USD Million)
Figure 29. Europe Biosimilar Drug Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Biosimilar Drug Revenue (2016-2026) & (USD Million)
Figure 31. South America Biosimilar Drug Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Biosimilar Drug Revenue (2016-2026) & (USD Million)
Figure 33. Global Biosimilar Drug Sales Market Share by Type (2016-2026)
Figure 34. Global Biosimilar Drug Revenue Market Share by Type (2016-2026)
Figure 35. Global Biosimilar Drug Price by Type (2016-2026) & (USD/Dose)
Figure 36. Global Biosimilar Drug Sales Market Share by Application (2016-2026)
Figure 37. Global Biosimilar Drug Revenue Market Share by Application (2016-2026)
Figure 38. Global Biosimilar Drug Price by Application (2016-2026) & (USD/Dose)
Figure 39. North America Biosimilar Drug Sales Market Share by Type (2016-2026)
Figure 40. North America Biosimilar Drug Sales Market Share by Application (2016-2026)
Figure 41. North America Biosimilar Drug Sales Market Share by Country (2016-2026)
Figure 42. North America Biosimilar Drug Revenue Market Share by Country (2016-2026)
Figure 43. United States Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Biosimilar Drug Sales Market Share by Type (2016-2026)
Figure 47. Europe Biosimilar Drug Sales Market Share by Application (2016-2026)
Figure 48. Europe Biosimilar Drug Sales Market Share by Country (2016-2026)
Figure 49. Europe Biosimilar Drug Revenue Market Share by Country (2016-2026)
Figure 50. Germany Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Biosimilar Drug Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Biosimilar Drug Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Biosimilar Drug Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Biosimilar Drug Revenue Market Share by Region (2016-2026)
Figure 59. China Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Biosimilar Drug Sales Market Share by Type (2016-2026)
Figure 66. South America Biosimilar Drug Sales Market Share by Application (2016-2026)
Figure 67. South America Biosimilar Drug Sales Market Share by Country (2016-2026)
Figure 68. South America Biosimilar Drug Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Biosimilar Drug Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Biosimilar Drug Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Biosimilar Drug Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Biosimilar Drug Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Biosimilar Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source

---